Provided by Tiger Fintech (Singapore) Pte. Ltd.

BridgeBio Pharma, Inc.

34.17
-0.6800-1.95%
Post-market: 34.13-0.0379-0.11%19:57 EDT
Volume:1.79M
Turnover:61.89M
Market Cap:6.49B
PE:-9.67
High:35.60
Open:35.43
Low:34.15
Close:34.85
Loading ...

UBS Adjusts BridgeBio Pharma Price Target to $54 From $47, Maintains Buy Rating

MT Newswires Live
·
25 Nov 2024

BridgeBio Pharma (BBIO) Receives a Hold from Oppenheimer

TIPRANKS
·
25 Nov 2024

BridgeBio price target raised to $48 from $45 at Scotiabank

TIPRANKS
·
25 Nov 2024

BridgeBio Soars After Drug Gets Nod in Rare Heart Condition

Bloomberg
·
25 Nov 2024

BridgeBio Pharma Shares up About 27% After FDA Approves Co's Heart Disease Drug

THOMSON REUTERS
·
25 Nov 2024

BridgeBio Pharma Gets FDA Approval for Heart Disease Drug Attruby

Dow Jones
·
25 Nov 2024

FDA Approves BridgeBio Pharma's Drug For Rare Heart Disease, Poised To Challenge Pfizer In Lucrative Yet Competitive Market

Benzinga
·
25 Nov 2024

BridgeBio Pharma Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
25 Nov 2024

BridgeBio Pharma (BBIO) Receives a Buy from Cantor Fitzgerald

TIPRANKS
·
25 Nov 2024

TD Cowen Remains a Buy on BridgeBio Pharma (BBIO)

TIPRANKS
·
25 Nov 2024

BridgeBio Pharma Inc : Raymond James Raises Target Price to $51 From $48

THOMSON REUTERS
·
25 Nov 2024

BridgeBio FDA approval ‘significant clearing event,’ says Citi

TIPRANKS
·
25 Nov 2024

BUZZ-BridgeBio jumps as FDA approves heart disease drug

Reuters
·
25 Nov 2024

BridgeBio Pharma Shares up About 25% Premarket After FDA Approves Co's Heart Disease Drug

THOMSON REUTERS
·
25 Nov 2024

BridgeBio Pharma Obtains FDA Approval of Attruby

MT Newswires Live
·
25 Nov 2024

BridgeBio price target raised to $45 from $42 at BofA

TIPRANKS
·
25 Nov 2024

BridgeBio Pharma (BBIO) Receives a Buy from Piper Sandler

TIPRANKS
·
25 Nov 2024

BridgeBio Pharma Inc : Scotiabank Raises Target Price to $48 From $45

THOMSON REUTERS
·
25 Nov 2024

BridgeBio Pharma Inc : Leerink Partners Raises Target Price to $47 From $46

THOMSON REUTERS
·
25 Nov 2024

BridgeBio announces FDA approved Attruby for ATTR-CM patients

TIPRANKS
·
23 Nov 2024